A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination

G Zhang, Y Cong, FL Liu, J Sun, J Zhang, G Cao… - Nature …, 2022 - nature.com
The global emergency caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic can only be solved with effective and widespread preventive and …

Interferon therapies in small animals

RS Mueller, K Hartmann - The Veterinary Journal, 2021 - Elsevier
Interferons (IFNs) are cytokines that play an important role in the immune response of
animals and humans. A number of studies reviewed here have evaluated the use of human …

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines

M Bhatta, S Nandi, S Dutta, MK Saha - Human vaccines & …, 2022 - Taylor & Francis
ABSTRACT COVID-19 is an international public health emergency in need of effective and
safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the …

Clinical HDAC inhibitors are effective drugs to prevent the entry of SARS-CoV2

K Liu, R Zou, W Cui, M Li, X Wang, J Dong… - ACS pharmacology & …, 2020 - ACS Publications
The outbreak of COVID-19 by the end of 2019 has posed serious health threats to humanity
and jeopardized the global economy. However, no effective drugs are available to treat …

Emerging viral diseases

A Majumdar, PK Jana - Viral infections and antiviral therapies, 2023 - Elsevier
Emerging and reemerging infectious diseases pose significant challenges to the human
population across the globe. Majority of these pathogens are RNA viruses and are zoonotic …

Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

RR Khanghah - 2022 - hal.science
Purpose: Ivermectin is a broad-spectrum antiparasitic and an effective drug to treat COVID-
19. In this article, we looked at the effects of ivermectin on coronavirus and its patients in …

A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort

B Cakir - European Journal of Clinical Microbiology & Infectious …, 2021 - Springer
Cag et al. have recently published their work entitled “A novel approach to managing COVID-
19 patients; results of lopinavir plus doxycycline cohort.” We congratulate the authors for …

Bioequivalence study of two favipiravir tablet formulations in healthy male subjects

O Sağlam, G Demiray, B Güney… - Authorea …, 2020 - authorea.com
Abstract Background: As WHO expresses, COVID-19 is the infectious disease caused by the
most recently discovered coronavirus. This new virus and disease were unknown before the …

Spike protein targeting “nano-glue” that captures and promotes SARS-CoV-2 elimination

G Zhang, Y Cong, G Cao, L Li, P Yu, Q Song, K Liu… - bioRxiv, 2021 - biorxiv.org
The global emergency caused by the SARS-CoV-2 pandemics can only be solved with
adequate preventive and therapeutic strategies, both currently missing. The electropositive …